| Dr.
Holger Mueller, Investment Director |
3i
Deutschland |
Karen
Hitschke,
Principal Healthcare Team |
Apax
Partners |
| Rob
Zegelaar, Senior Principal |
Atlas
Venture |
Prof.
Dr. Jesper Zeuthen,
Managing Director |
BankInvest
Bio Venture |
| Prof.
Dr. Horst Domdey, CEO |
BioM |
| Dr.
Marion Dörner, Principal |
Earlybird
Venture Capital GmbH & Co KG |
Peter
Kuchenbuch ,
Life Science Correspondent |
Financial
Times Deutschland |
| Dr.
Jens A. Katzek, Managing Director |
German
Association of Biotechnology Industries (DIB) |
Dr
Ann Mills-Duggan,
Director, Asset Screening - Europe, Genetics & Discovery Ventures |
GlaxoSmithKline |
| Hanns-Peter
Wiese, Partner |
Global
Life Science Ventures GmbH |
| Dr.
Andreas Wicki, Board Member & CEO |
HBM
Partners AG |
| Susan
Searle, Managing Director |
Imperial
College Innovations |
| Prof.
Chris Toumazou, Head of Department, Bioengineering |
Imperial
College of Science, Technology & Medicine |
| Conny
Bogentoft , Managing Director |
Karolinska
Innovations AB |
| Stan
Yakatan, Chairman |
Katan
Associates |
Mark
Clement,
MD of European Operations |
Merlin
Biosciences |
Mr.
Adi Seffer,
Partner |
Morgan
Lewis & Bockius LLP,
Frankfurt am Main |
Dr.
Christian Zschocke,
Managing Director |
Morgan
Lewis & Bockius LLP
|
| Dr.
Michael Steinmetz, General Partner |
MPM
Capital |
| André
Lamotte, Founder |
NMT
Management AG |
Dr.
Romeo Paioni,
Head of Scientific and External Affairs |
Novartis
Pharma AG |
| Michael
Lytton, General Partner |
Oxford
Bioscience Partners |
Dr.
Silvano Fumero,
Senior Executive Vice-President,
Head of Research & Pharmaceutical Development, |
Serono
International S.A. |
| Bernard
Gilly , Partner, |
Sofinnova
Partners |
Robert
Wyss ,
Head of New Market |
SWX
Swiss Exchange |
| Dr.
Hubert Birner, Partner, |
Techno
Venture Management |
| Nick
Lowcock, Managing Director |
Warburg
Pincus |
